MENU
FTH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Faeth Therapeutics (FTH) Ownership - Who owns Faeth Therapeutics?

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways... Show more

Profile

Industry
N/A
Address
701 Tillery Street No. 12, No.1010
Phone
+1 240 243-8000
Employees
29
Web
https://www.faeththerapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
959.97M
P/E Ratio
N/A
Total Cash
186.44M
Projected Growth
N/A
Total Debt
592K
Revenue
N/A
Risk (Beta)
-1.04
Dividend Yield
N/A
Total Cash/Share
7.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
FTH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
701 Tillery Street No. 12, No.1010
Phone
+1 240 243-8000
Employees
29
Web
https://www.faeththerapeutics.com